Operating Data

TRxADE HEALTH, Inc. (MEDS)

$ 4.4837
-0.5263 (-10.50%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.961.502.912.482.933.837.4417.1227.1443.0268.19108.09171.32
Revenue (%)
EBITDA -2.08-1.43-0.13-2.610.450.07-0.05-1.68-14.12-22.38-35.47-56.22-89.12
EBITDA (%)
EBIT -2.08-1.43-0.14-2.620.440.06-0.07-1.73-14.20-22.50-35.67-56.54-89.61
EBIT (%)
Depreciation 0000.010.010.010.020.050.080.120.200.310.50
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)